Delivery Order SPE2DB20D1109-SPE2DB24FP70S

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,376.35, is for the procurement of DUOVISC VISCOELASTIC SYSTEM 1.05ML, a medical product. The contract is a firm fixed-price delivery order with a completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of a DUOVISC Viscoelastic System medical product. The contract has a ceiling value of $7,950.30 and an ultimate completion date of August 30, 2024. It is a firm-fixed-price contract with no set-aside designation. Amerisourcebergen, through its extensive supply chain network, will provide this critical medical...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,618.43 firm fixed price contract covers the procurement of a DUOVISC Viscoelastic System medical product. The order has a completion date of December 17, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of a pharmaceutical product called DUOVISC Viscoelastic System 1.05ML, with a ceiling value of $9,301.36 and a completion date of May 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA to...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,614.69, is for the procurement of the DUOVISC VISCOELASTIC SYSTEM 1.05ML medical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 20, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,650.10, is for the delivery of a DUOVISC viscoelastic system product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a Delivery Order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract is for the provision of the DUOVISC VISCOELASTIC SYSTEM 1.05ML, a medical supply item, with a ceiling value of $2,650.10 and a period of performance through May 2, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp. The $8,960.10 firm fixed price delivery order is for the procurement of 4,567,011 units of the DUOVISC VISCOELASTIC SYSTEM 1.05ML medical product. The contract has an ultimate completion date of January 23, 2025. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a...
This is a delivery order award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the DUOVISC Viscoelastic System 1.05ML, a pharmaceutical product, with a firm fixed price of $1,590.06 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as the primary vendor for an indefinite delivery contract (IDC) with DLA to provide pharmaceuticals and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the provision of medical products, specifically the DUOVISC VISCOELASTIC SYSTEM 1.05ML. The contract has a ceiling value of $8,685.81 and is a firm fixed-price delivery order with an ultimate completion date of April 22, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP70S
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of the DUOVISC VISCOELASTIC SYSTEM 1.05ML medical product. The firm-fixed-price contract has a ceiling value of $2,429.17 and a completion date of August 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. This delivery order does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:56 AM